TY - JOUR KW - Adolescent KW - Adult KW - Aged KW - Dapsone KW - Drug Hypersensitivity KW - Drug Therapy, Combination KW - Female KW - Humans KW - Leprostatic Agents KW - leprosy KW - Male KW - Middle Aged KW - Nepal AU - Pandey B AU - Shrestha K AU - Lewis J AU - Hawksworth R A AU - Walker S L AB -

Dapsone is a component of multi-drug therapy (MDT) for the treatment of all types of leprosy. It is known that dapsone hypersensitivity syndrome (DHS) complicates the treatment in a proportion of patients. We performed a retrospective study of patients commenced on MDT between 1990 and 2006; 2% developed DHS and 0.25% died due to DHS.

BT - Tropical doctor C1 - http://www.ncbi.nlm.nih.gov/pubmed/17716505?dopt=Abstract CN - PANDEY 2007 DA - 2007 Jul DO - 10.1258/004947507781524700 IS - 3 J2 - Trop Doct LA - eng N2 -

Dapsone is a component of multi-drug therapy (MDT) for the treatment of all types of leprosy. It is known that dapsone hypersensitivity syndrome (DHS) complicates the treatment in a proportion of patients. We performed a retrospective study of patients commenced on MDT between 1990 and 2006; 2% developed DHS and 0.25% died due to DHS.

PY - 2007 SP - 162 EP - 3 T2 - Tropical doctor TI - Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal. UR - http://tdo.sagepub.com/content/37/3/162.full.pdf+html VL - 37 SN - 0049-4755 ER -